Ram Kumar Selvaraju
About
In The Last Decade
Ram Kumar Selvaraju
35 papers receiving 936 citations
Peers
Comparison fields: 5 of 83
- Radiology, Nuclear Medicine and Imaging 336
- Oncology 320
- Surgery 282
- Molecular Biology 250
- Epidemiology 220
Countries citing papers authored by Ram Kumar Selvaraju
This map shows the geographic impact of Ram Kumar Selvaraju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram Kumar Selvaraju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram Kumar Selvaraju more than expected).
Fields of papers citing papers by Ram Kumar Selvaraju
This network shows the impact of papers produced by Ram Kumar Selvaraju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram Kumar Selvaraju. The network helps show where Ram Kumar Selvaraju may publish in the future.
Co-authorship network of co-authors of Ram Kumar Selvaraju
This figure shows the co-authorship network connecting the top 25 collaborators of Ram Kumar Selvaraju. A scholar is included among the top collaborators of Ram Kumar Selvaraju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram Kumar Selvaraju. Ram Kumar Selvaraju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 10 | |
| 6 | 11 | |
| 7 | 27 | |
| 8 | 26 | |
| 9 | 9 | |
| 10 | Dosimetry of [Ga-68]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human | 1 |
| 11 | 22 | |
| 12 | 14 | |
| 13 | 30 | |
| 14 | 18 | |
| 15 | Feasibility of radionuclide imaging of HER3-expressing tumours using technetium-99m labeled affibody molecules | 0 |
| 16 | 50 | |
| 17 | Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules | 1 |
| 18 | Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA | 0 |
| 19 | Pancreatic uptake of [68Ga]DO3A-Exendin4 is mediated by the GLP-1 receptor | 0 |
| 20 | 65 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.